FATE
Fate Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.45
+0.03 (+1.24%)
Rating:C
Company Profile
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.42
Prev. Close
$2.42
Day Low
$2.39
Day High
$2.52
52W Low
$0.91
52W High
$2.88
Market Cap
$0.29B
Volume
0.40M